The beneficial effect of salubrinal on neuroinflammation and neuronal loss in intranigral LPS-induced hemi-Parkinson disease model in rats

References

• Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet. 2009;373(9680):2055–2066.
   PubMed Web of Science ®Google Scholar
• Guzman-Martinez L, Maccioni RB, Andrade V, et al. Neuroinflammation as a common feature of neurodegenerative disorders. Front Pharmacol. 2019;10(SEP):1008.
   PubMedGoogle Scholar
• Caggiu E, Arru G, Hosseini S, et al. Inflammation, infectious triggers, and Parkinson’s disease. Front Neurol. 2019;1:122.
   Google Scholar
• Sochocka M, Diniz BS, Leszek J. Inflammatory response in the CNS: friend or foe? Mol Neurobiol. 2017;54(10):8071–8089.
   PubMed Web of Science ®Google Scholar
• Stratoulias V, Venero JL, Tremblay M, et al. Microglial subtypes: diversity within the microglial community. Embo J. 2019;38(17):e101997.
   PubMed Web of Science ®Google Scholar
• Asanuma M, Miyazaki I, Ogawa N. Neuroprotective effects of nonsteroidal anti-inflammatory drugs on neurodegenerative diseases. Curr Pharm Des. 2004;10(6):695–700.
   PubMed Web of Science ®Google Scholar
• Gagne JJ, Power MC. Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis. Neurology. 2010;74(12):995–1002.
   PubMed Web of Science ®Google Scholar
• Stayte S, Vissel B. Advances in non-dopaminergic treatments for Parkinson’s disease. Front Neurosci. 2014; 8(8):113.
   PubMedGoogle Scholar
• Cook C, Stetler C, Petrucelli L. Disruption of protein quality control in Parkinson's disease. Cold Spring Harb Perspect Med. 2012;2(5):a009423.
   PubMed Web of Science ®Google Scholar
• Pintado C, MacIás S, Domínguez-Martín H, et al. Neuroinflammation alters cellular proteostasis by producing endoplasmic reticulum stress, autophagy activation and disrupting ERAD activation. Sci Rep. 2017;7(1):8100.
   PubMedGoogle Scholar
• Sprenkle NT, Sims SG, Sánchez CL, et al. Endoplasmic reticulum stress and inflammation in the Central nervous system. Mol Neurodegener. 2017;12(1):1–18.
   PubMedGoogle Scholar
• Omura T, Kaneko M, Okuma Y, et al. Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease. Oxid Med Cell Longev. 2013;2013:239854.
   PubMed Web of Science ®Google Scholar
• Mercado G, Castillo V, Vidal R, et al. ER proteostasis disturbances in Parkinson’s disease: novel insights. Front Aging Neurosci. 2015;7:39.
   PubMed Web of Science ®Google Scholar
• Cnop M, Ladriere L, Hekerman P, et al. Selective inhibition of eukaryotic translation initiation factor 2 alpha dephosphorylation potentiates fatty acid-induced endoplasmic reticulum stress and causes pancreatic beta-cell dysfunction and apoptosis. J Biol Chem. 2007;282(6):3989–3997.
   PubMed Web of Science ®Google Scholar
• Matsuoka M, Komoike Y. Experimental evidence shows salubrinal, an eIF2α dephosphorylation inhibitor, reduces xenotoxicant-induced cellular damage. Int J Mol Sci. 2015;16(7):16275–16287.
   PubMed Web of Science ®Google Scholar
• Jiang P, Gan M, Ebrahim AS, et al. ER stress response plays an important role in aggregation of -synuclein. Mol Neurodegener. 2010;5(1):56.
   PubMedGoogle Scholar
• Du Sert NP, Hurst V, Ahluwalia A, et al. The arrive guidelines 2.0: updated guidelines for reporting animal research. PLoS Biol. 2020;18(7):e3000410.
   PubMed Web of Science ®Google Scholar
• Wang Z. F, Gao C, Chen W, et al. Salubrinal offers neuroprotection through suppressing endoplasmic reticulum stress, autophagy and apoptosis in a mouse traumatic brain injury model. Neurobiol Learn Mem. 2019;161:12–25.
   PubMed Web of Science ®Google Scholar
• Rubovitch V, Barak S, Rachmany L, et al. The neuroprotective effect of salubrinal in a mouse model of traumatic brain injury. Neuromolecular Med. 2015;17(1):58–70.
   PubMed Web of Science ®Google Scholar
• Gao B, Zhang XY, Han R, et al. The endoplasmic reticulum stress inhibitor salubrinal inhibits the activation of autophagy and neuroprotection induced by brain ischemic preconditioning. Acta Pharmacol Sin. 2013;34(5):657–666.
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in stereotaxic coordinates: compact. 6th ed. San Diego, USA: Elsevier Acad Press. 2009.
   Google Scholar
• Hsieh TH, Chen JJJ, Chen LH, et al. Time-course gait analysis of hemiparkinsonian rats following 6-hydroxydopamine lesion. Behav Brain Res. 2011;222(1):1–9.
   PubMed Web of Science ®Google Scholar
• Su RJ, Zhen JL, Wang W, et al. Time-course behavioral features are correlated with parkinson’s disease-associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. Mol Med Rep. 2018;17(2):3356–3363.
   PubMed Web of Science ®Google Scholar
• Ogawa N, Hirose Y, Ohara S, et al. A simple quantitative bradykinesia test in MPTP-treated mice. Res Commun Chem Pathol Pharmacol. 1985;50(3):435–441.
   PubMedGoogle Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
   PubMed Web of Science ®Google Scholar
• Jamali-Raeufy N, Mojarrab Z, Baluchnejadmojarad T, et al. The effects simultaneous inhibition of dipeptidyl peptidase-4 and P2X7 purinoceptors in an in vivo Parkinson's disease model. Metab Brain Dis. 2020;35(3):539–548.
   PubMed Web of Science ®Google Scholar
• Segura-Aguilar J. On the role of aminochrome in mitochondrial dysfunction and endoplasmic reticulum stress in Parkinson’s. Front Neurosci. 2019;13:271.
   PubMed Web of Science ®Google Scholar
• Castaño A, Herrera AJ, Cano J, et al. The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem. 2002;81(1):150–157.
   PubMed Web of Science ®Google Scholar
• Tansey MG, Goldberg MS. Neuroinflammation in Parkinson's disease: its role in neuronal death and implications for therapeutic intervention. Neurobiol Dis. 2010;37(3):510–518.
   PubMed Web of Science ®Google Scholar
• Tanabe K, Matsushima-Nishiwaki R, Yamaguchi S, et al. Mechanisms of tumor necrosis factor-alpha-induced interleukin-6 synthesis in glioma cells. J Neuroinflammation. 2010;7:16.
   PubMed Web of Science ®Google Scholar
• Tabrez S,R, Jabir N, Shakil S, et al. A synopsis on the role of tyrosine hydroxylase in Parkinson's disease. CNS Neurol Disord Drug Targets. 2012;11(4):395–409.
   PubMed Web of Science ®Google Scholar
• Zhu X, Huang L, Gong J, et al. NF-κB pathway link with ER stress-induced autophagy and apoptosis in cervical tumor cells. Cell Death Discov. 2017;3:17059.
   PubMed Web of Science ®Google Scholar
• Yuste JE, Tarragon E, Campuzano CM, et al. Implications of glial nitric oxide in neurodegenerative diseases. Front Cell Neurosci. 2015;9:322.
   PubMed Web of Science ®Google Scholar
• Gelders G, Baekelandt V, Van der Perren A. Linking neuroinflammation and neurodegeneration in Parkinson's Disease. J Immunol Res. 2018;2018:4784268.
   PubMed Web of Science ®Google Scholar
• Schmitz ML, Shaban MS, Albert BV, et al. The crosstalk of endoplasmic reticulum (ER) stress pathways with NF-κB: complex mechanisms relevant for cancer, inflammation and infection. Biomedicines. 2018;6(2):58.
   Web of Science ®Google Scholar
• Andreakos E, Sacre SM, Smith C, et al. Distinct pathways of LPS-induced NF-kappa B activation and cytokine production in human myeloid and nonmyeloid cells defined by selective utilization of MyD88 and Mal/TIRAP . Blood. 2004;103(6):2229–2237.
   PubMed Web of Science ®Google Scholar
• Arias-Salvatierra D, Silbergeld EK, Acosta-Saavedra LC, et al. Role of nitric oxide produced by iNOS through NF-κB pathway in migration of cerebellar granule neurons induced by lipopolysaccharide. Cell Signal. 2011;23(2):425–435.
   PubMed Web of Science ®Google Scholar
• Logsdon AF, Lucke-Wold BP, Nguyen L, et al. Salubrinal reduces oxidative stress, neuroinflammation and impulsive-like behavior in a rodent model of traumatic brain injury. Brain Res. 2016;1643:140–151.
   PubMed Web of Science ®Google Scholar
• Aïd S, Bosetti F. Targeting cyclooxygenases-1 and -2 in neuroinflammation: therapeutic implications. Biochimie. 2011;93(1):46–51.
   PubMed Web of Science ®Google Scholar
• Choi JH, Moon CM, Shin TS, et al. Lactobacillus paracasei-derived extracellular vesicles attenuate the intestinal inflammatory response by augmenting the endoplasmic reticulum stress pathway. Exp Mol Med. 2020;52(3):423–437.
   PubMed Web of Science ®Google Scholar
• Yu SM, Kim SJ. Endoplasmic reticulum stress (ER-stress) by 2-deoxy-d-glucose (2DG) reduces cyclooxygenase-2 (COX-2) expression and N-glycosylation and induces a loss of COX-2 activity via a Src kinase-dependent pathway in rabbit articular chondrocytes. Exp Mol Med. 2010;42(11):777–786.
   PubMed Web of Science ®Google Scholar
• Anuncibay-Soto B, Pérez-Rodriguez D, Santos-Galdiano M, et al. Salubrinal and robenacoxib treatment after global cerebral ischemia. exploring the interactions between ER stress and inflammation. Biochem Pharmacol. 2018;151:26–37.
   PubMed Web of Science ®Google Scholar
• Hamamura K, Nishimura A, Chen A, et al. Salubrinal acts as a Dusp2 inhibitor and suppresses inflammation in anti-collagen antibody-induced arthritis. Cell Signal. 2015;27(4):828–835.
   PubMed Web of Science ®Google Scholar
• Jeffrey KL, Camps M, Rommel C, et al. Targeting dual-specificity phosphatases: manipulating MAP kinase signalling and immune responses. Nat Rev Drug Discov. 2007;6(5):391–403.
   PubMed Web of Science ®Google Scholar